Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
9
Bearish filings
0
Named actors
9
Disclosed $ (bull / bear)
$134K / $0
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-31 | 5%+ holder (13G) Stonepine Capital Management, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-17 | Activist (13D) Nantahala Capital Partners Limited Partnership | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-14 | 5%+ holder (13G) Rosalind Advisors, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-07 | Chief Executive Officer Lee-Sepsick Kathy | bought | $50K | SEC ↗ |
| 2026-08-07 | Chief Financial Officer Elefant Dov | bought | $50K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-07 | Chief Operating Officer Canning John Charles | bought | $14K | SEC ↗ |
| 2026-08-07 | Chief Technology Officer Sipos Jeremy Alexander | bought | $10K | SEC ↗ |
| 2026-08-07 | Chief Clinical-Medical Affairs Mifek Jeffrey Gerald | bought | $10K | SEC ↗ |
| 2026-03-18 | 5%+ holder (13G) PharmaCyte Biotech, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |